Replies to post #263168 on Anavex Life Sciences Corp (AVXL)

[OFP]

Focus on the important NEWS...Australia approval.

This is not important news....the SAS path is specifically for non-approved drugs. There is no indication or expectation that this will be for more than the 10 or so remaining patients in the OLE

[scottmiyadi]

Could not agree more--- anything else ignores the 900 lb gorilla in the room! Same lame q&a that fails to address why we are all here in the first place --- cant they at least try to be a journalist rather than f'n lame analysts for crying out loud. We had seemingly significant news and were talking about Rett subset groups<,,,,,,,,,, gtfo!!!

[Spudskie]

What you call “important”, the market says “meh”.